Due to increased levels of IL-38 and decreased levels of MIP-2 expression in dexamethasone-receiving mice in comparison with bleomycin-receiving ones, they concluded that IL-38 can act as an immunomodulatory agent in the immunopathogenesis of pulmonary fibrosis [184]. Here, IL1F10 is linked to pulmonary fibrosis.